Answering Reader Questions on Flu, COVID-19, and RSV Rates Using Latest Cdc/mmwr Reports
CDC and MMWR Data Indicate Rising U.S. Respiratory Illness Trends and Low Adult Vaccination Coverage
Read More →Policy & Explainers
Legislation, oversight, and evergreen explainers grounded in primary documents.
FDA Outlines New Regulatory Expectations for AI-Powered Wearables and Apps Tracking Heart Metrics
FDA Clarifies Regulatory Expectations for AI in Cardiovascular Monitoring Tools
Read More →Uspstf Evidence Review on PSA-Based Screening for Prostate Cancer
Primary Evidence on Benefits and Harms of PSA-Based Prostate Cancer Screening
Read More →GLP-1 Medications Explained Through FDA, NEJM, and JAMA Evidence
FDA and NEJM Sources Detail Semaglutide for Chronic Weight Management
Read More →Men’s Heart Disease Risk: Answering Common Questions Using Latest CDC and NIH Data
Heart disease stands as the leading cause of death for men in the United States. It accounts for approximately one in…
Read More →FDA Requires Updated Warnings on Cardiovascular Risks for Certain Prostate Cancer Treatments
FDA Updates Labeling for GnRH Agonists With New Warnings on Diabetes and Cardiovascular Risks
Read More →Bird Flu 2024: Answering Key Questions Using CDC and WHO Primary Reports
What are the human health risks from Avian Influenza A(H5N1)?
Read More →What the 2021 Uspstf Colorectal Cancer Screening Recommendation Means
2021 USPSTF Update Lowers Colorectal Cancer Screening Start Age to 45 for Average-Risk Adults
Read More →Answering Key Questions from the Uspstf Evidence Review on PSA-Based Screening
The USPSTF concludes with moderate certainty that PSA-based screening for prostate cancer in men ages 55-69 offers a…
Read More →FDA Clearance Pathways and Evidence for Cardiovascular Wearables
The FDA evaluates consumer wearables that monitor for signs of atrial fibrillation through its Digital Health Center…
Read More →FDA Labels, NEJM Trial Data, and NIH Findings on Semaglutide and Tirzepatide
Primary regulatory and clinical trial sources indicate that GLP-1 receptor agonists such as semaglutide produce…
Read More →Multiple Trials Show Lean Mass Loss Alongside Fat Reduction in Obesity Treatments
Three trials published in The New England Journal of Medicine tracked body composition changes during treatment with…
Read More →How the FDA Determines Which Wellness Apps Are Regulated as Medical Devices
The FDA regulates digital health applications that qualify as medical devices if their intended use involves…
Read More →Sleep and Testosterone: Answering Reader Questions from CDC and NIH Primary Reports
CDC and NIH sources state that adults need 7 or more hours of sleep per night. NIH materials link sleep restriction…
Read More →Heart Disease in Men: Answering Common Questions from Latest CDC Reports
What do CDC and MMWR data reveal about cardiovascular risk factors in men?
Read More →What Registry Data Show About Emerging Digital Prevention Approaches for Men's Heart Health
NIH-Funded Research Examines Digital Tools for Cardiovascular Risk Monitoring in Men
Read More →Uspstf Prostate Cancer Screening Recommendations: Evidence-Based Questions and Official Answers
The U.S. Preventive Services Task Force set its current standards for PSA-based prostate cancer screening in a 2018…
Read More →Heart Disease in Men: Answering Common Questions Using Latest CDC Reports
CDC and MMWR Data Show High Rates of Cardiovascular Risk Factors in Middle-Aged U.S. Men
Read More →Cardiovascular Risk in Men: Answering Common Questions Using Latest CDC and NIH Reports
CDC and NIH Data Show High Prevalence of Cardiovascular Risk Factors Among U.S. Men Aged 40-59
Read More →FDA Clearance Pathways and AHA Statements on Consumer Wearables for Heart Health Monitoring
FDA Clearance Pathways and AHA Statements on Consumer Wearables for Heart Health Monitoring
Read More →How the FDA Classifies and Reviews Digital Tools for Wellness Tracking
How the FDA Classifies and Reviews Digital Tools for Wellness Tracking
Read More →Q&A: Current Uspstf Guidance on PSA-Based Prostate Cancer Screening for Men
Q&A: USPSTF Guidance on PSA-Based Prostate Cancer Screening for Men
Read More →Q&A: FDA-Authorized Digital Therapeutics for Anxiety and Depression – What the Primary Documents Show
Q&A: FDA-Authorized Digital Therapeutics for Anxiety and Depression – What the Primary Documents Show
Read More →FDA Implements New Regulatory Framework for Lab-Developed Tests After Years of Debate
FDA Implements New Regulatory Framework for Lab-Developed Tests After Years of Debate
Read More →Q&A: Key Facts from CDC’s MMWR on Heart Disease in Men
Q&A: Key Facts from CDC’s MMWR on Heart Disease in Men
Read More →FDA Detects Undeclared Sildenafil and Tadalafil in OTC Male Sexual Enhancement Products
FDA Detects Undeclared Sildenafil and Tadalafil in OTC Male Sexual Enhancement Products
Read More →CDC Data on Leading Heart Disease Risks for Men
CDC and MMWR Reports on Cardiovascular Risk Factors in Men
Read More →What CDC and WHO Primary Reports State About Daily Sitting Time and Health Metrics
What CDC and WHO Primary Reports State About Daily Sitting Time and Health Metrics
Read More →FDA Regulatory Framework for Digital Health and Wellness Technologies
FDA Regulatory Framework for Digital Health and Wellness Technologies
Read More →What FDA Clearance Actually Means for Digital Mental Wellness Apps
What FDA Clearance Actually Means for Digital Mental Wellness Apps
Read More →